Sitemap

• Home
• Science
  • Curated Science
  • Diabetes
    • Curated Science
      • In Range Study
      • T1 Evidence in Adults
      • T1DM - Meta-Analysis
      • T1 Evidence in Children
      • Edition Junior Study
      • Video: BRIGHT study
      • Head-to-head studies Trurapi^®▼ (Insulin Aspart 100 units/ml) (GB only) vs NovoRapid^®
      • ORION Observational Study
      • SPARTA study
  • Dyslipidaemia
    • Curated science
      • OUTCOMES IN DIABETES PATIENTS
      • FH I & FH II Studies | Praluent^® (alirocumab)
      • A cardiologist's view - Professor Azfar Zaman
      • Praluent^® (alirocumab) PubExplainer
      • Mechanism of Action | Praluent^® alirocumab
      • Dosing | Praluent^® alirocumab
      • ODYSSEY OUTCOMES | Trial Design
      • ODYSSEY OUTCOMES | Efficacy
      • ODYSSEY OUTCOMES | Safety Profile
      • NICE & SMC Guidance
      • Dyslipidaemia guidelines interactive tool
      • Dyslipidaemia guidelines interactive tool
      • Dyslipidaemia guidelines interactive tool
      • Specific Characteristics of Praluent^® (alirocumab)
      • Unmet Need | Praluent^® alirocumab
      • Indication | Praluent^® alirocumab
      • Administration | Praluent^® alirocumab
  • Neurology
    • Multiple Sclerosis
      • Curated Science
        • AUBAGIO^® (teriflunomide) – Real-World Considerations
        • Academy of Knowledge Hub
        • Sanofi’s Heritage in MS
    • Academy of Knowledge | MS Scientific Exchange Forum
      • AUBAGIO^® (teriflunomide): MoA and Safety - Prof. Patrick Vermersch
      • Curated Science
      • Preserving Brain Health | Part 1: Underlying Pathology of Chronic Smouldering MS - Prof. Gavin Giovannoni
      • AUBAGIO^® (teriflunomide) Overview: Efficacy (Brain Health) and Real-World (Patient-Reported Outcomes, Adherence, Effectiveness) - Prof. Jiwon Oh
      • Preserving Brain Health | Part 2: Clinical Progression and Smouldering Disease - Prof. Gavin Giovannoni
      • Preserving Brain Health | Part 3: Advanced Imaging Techniques in Routine Clinical Practice - Prof. Jiwon Oh
  • Rare Blood Disorders
    • Curated Science
      • What is aTTP?
      • Diagnosis of aTTP
  • Rare Diseases
    • Fabry disease
      • Curated Science
        • Fabry disease and Cardiology
          • Understanding Fabry disease
          • Recognising Fabry disease in clinical practice
          • Clinical genetics
          • Fabry disease pathophysiology
          • Screening strategies
          • Evolving role of AI in the diagnosis of Fabry disease
        • Fabry disease and Nephrology
          • Monitoring Fabry disease and nephropathy
          • Fabry disease and unexplained CKD
          • Screening strategies in Fabry disease
          • Podocytes and Fabry disease
          • Clinical genetics
          • Fabry disease nephropathy
    • Gaucher disease
      • Curated science
        • The patient's experience - Sarah
        • The patient's experience - Janet
        • The patient’s experience - Peter
        • What is Gaucher disease?
        • Signs and Symptoms of Gaucher disease
        • Epidemiology of Gaucher disease
        • Diagnosis of Gaucher disease
        • Gaucher disease Management and Specialist Treatment Centres
      • Expert hub
        • Summary of Gaucher Disease – Dr Richard Soutar
        • Gaucher Talking Heads Video – Dr Mohsen Norouzi
        • Gaucher Talking Heads Video – Professor Tim Cox
    • MPS I
      • Curated Science
        • What is MPS I?
        • Signs and Symptoms of MPS I
        • Diagnosis and Misdiagnosis of MPS I
        • What is MPS I?
        • How does MPS Present?
        • What are the attenuated features of MPS diagnosed in adults?
        • How can early diagnosis of new born MPS patients be achieved?
        • How to test for MPS?
        • Specialist Treatment Centres for Metabolic Diseases
    • Pompe Disease
      • Curated Science
        • What is Pompe disease?
        • Signs and Symptoms of Pompe disease
        • Treatment and Specialist Treatment Centres in the UK for Pompe disease
  • Thrombosis
    • Curated science
      • Indication and Mechanism of action of Clexane (enoxaparin)
      • Venous Thromboembolism & Pulmonary Embolism
      • Social Value And Net Zero In NHS Procurement
      • Prescribe by brand name
      • Clexane (enoxaparin) Administration, Devices and Doses
      • Cancer-associated thrombosis
      • Treatment of CAT
  • Transplant
    • Curated Science
      • Efficacy
      • Safety
  • Get in Touch with Us
  • Get in Touch with Us - Diabetes UK 2023
  • Vaccines
    • Curated Science
      • Burden of Influenza
      • Enhanced Inactivated Flu Vaccines
      • Recombinant Flu (Influenza) Vaccine
• Products
  • Diabetes
    • TOUJEO^® (INSULIN GLARGINE 300 UNITS/ML)
    • TRURAPI^®▼ (INSULIN ASPART 100 UNITS/ML) (GB ONLY)
      • Savings
      • Form
    • ADMELOG^® (INSULIN LISPRO 100 UNITS/ML) (GB ONLY)
      • Savings
    • Lantus^® (insulin glargine 100 units/mL)
    • Lyxumia^® (lixisenatide)
    • Insuman^® (insulin human)
  • Dyslipidaemia
    • Praluent^® (alirocumab)
  • Neurology
    • AUBAGIO^® (TERIFLUNOMIDE)
  • Oncology
    • Sarclisa^®▼
  • Rare Blood Disorders
    • CABLIVI^®▼(CAPLACIZUMAB) the black triangle symbol only applies to Great Britain
  • Rare Diseases
    • MYOZYME^® (ALGLUCOSIDASE ALFA)
    • CERDELGA^®▼ (HARD CAPSULES ELIGLUSTAT)
    • CEREZYME^® (IMIGLUCERASE FOR INJECTION)
    • Nexviadyme^®▼ (avalglucosidase alfa) (GB only)
    • Fabrazyme
  • Transplant
    • REZUROCK^®▼(belumosudil) tablets
  • Thrombosis
    • Clexane (enoxaparin)
  • Vaccines
    • Travel vaccines
      • AVAXIM^® Hepatitis A vaccine (inactivated, adsorbed)
      • AVAXIM^® JUNIOR Hepatitis A vaccine (inactivated, adsorbed)
      • MenQuadfi^TM▼ Meningococcal (Group A,C,W,Y) Conjugate Vaccine
      • REVAXIS^® Diphtheria, Tetanus & Poliomyelitis (inactivated) Vaccine (absorbed, reduced antigen(s) content)
      • TYPHIM Vi^® (Typhoid Polysaccharide Vaccine)
    • Influenza vaccines
      • Supemtek^®▼Quadrivalent Influenza Vaccine (recombinant, prepared in cell culture)
      • Quadrivalent Influenza Vaccine (split virion, inactivated) suspension for injection in pre-filled syringe
    • Paediatric Vaccines
      • MenQuadfi^TM▼ Meningococcal (Group A,C,W,Y) Conjugate Vaccine
      • REPEVAX^® Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
      • REVAXIS^® Diphtheria, Tetanus & Poliomyelitis (inactivated) Vaccine (absorbed, reduced antigen(s) content)
      • VAXELIS^® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed)
• Patient Support
  • Diabetes
  • dyslipidemia
    • Praluent^® (alirocumab)
      • Homecare
      • MyPraluent^® Coach
      • Patient profiles
      • Patient Resources
  • Neurology
    • Multiple Sclerosis
  • Rare Blood Disorders
    • Resources and Tools
      • Rare Blood Disorders Patient Support
  • Rare Diseases
    • MPS I
      • Patient Support
        • MPS I Physiotherapy Flipbook
      • Resources and Tools
        • MPS I Disease Awareness Slide Deck
    • Pompe disease
      • Resources and Tools
        • ItsInYourMuscles
    • Gaucher disease
      • Resources and Tools
        • Patient Organisation website
        • Downloadable PDF: Signs & Symptoms of Gaucher disease
        • Diagnostic Algorithms for Gaucher disease
        • Cerdelga▼ Patient Materials
  • Thrombosis
    • Clexane (enoxaparin)
  • Vaccines
    • Get in Touch with the Vaccines Team
    • Hajj and Umrah traveller health recommendations
    • Hepatitis A booster campaigns
• Events
  • Diabetes
    • Pitstop | Diabetes
  • Rare blood disorders
    • Differential Diagnosis of Thrombotic Microangiopathies (TMA)
  • Neurology
    • OptiMiSe 2023
• Education
  • Diabetes
  • Dyslipidaemia
  • Vaccines
    • Vaccines Training
  • Curated Education
• Maintenance
• Search
• Terms of Use
• Cookie Policy
• 404 Error
• Coming Soon
• Staying in Touch
• Login
• Registration
• My Account
  • Change Password
  • Unsubscribe